I. Wieselgren

发表

D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

M. Bergström, B. Långström, F. Wiesel, 2001, European Neuropsychopharmacology.

Symptoms at index admission as predictor for 1‐5 year outcome in schizophrenia

E. Lindström, L. Lindström, I. Wieselgren, 1996, Acta psychiatrica Scandinavica.

Schizophrenia and Antipsychotic Somatic Treatment

L. Lindström, I. Wieselgren, Leif Lindström, 1996, International Journal of Technology Assessment in Health Care.

Acid monoamine metabolites in the CSF of healthy controls punctured without preceding strict bedrest: a retrospective study.

L. Lindström, I. Wieselgren, C. Nordin, 1996, Journal of psychiatric research.

A prospective 1–5 year outcome study in first‐admitted and readmitted schizophrenic patients; relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment

L. Lindström, I. Wieselgren, Leif Lindström, 1996, Acta psychiatrica Scandinavica.

Five-year outcome of first-episode psychosis before and after the implementation of a modified assertive community treatment programme

J. Sundström, L. Lindström, I. Wieselgren, 2010, Social Psychiatry and Psychiatric Epidemiology.

Treatment costs and clinical outcome for first episode schizophrenia patients: a 3‐year follow‐up of the Swedish ‘Parachute Project’ and Two Comparison Groups

S. Levander, I. Wieselgren, J. Cullberg, 2006, Acta psychiatrica Scandinavica.

Pharmacokinetic and Biopharmaceutic Aspects of Once Daily Treatment with Metoprolol CR/ZOK: A Review Article

R. Bergstrand, C. Regårdh, B. Abrahamsson, 1990, Journal of clinical pharmacology.

Pharmacokinetic and Pharmacodynamic Evaluation of Metoprolol Controlled Release (CR/ZOK) 50 mg in Young Subjects

R. Bergstrand, P. Lundborg, I. Wieselgren, 1990, Journal of clinical pharmacology.

Pharmacokinetic and Pharmacodynamic Comparison of Metoprolol CR/ZOK Once Daily with Conventional Tablets Once Daily and in Divided Doses

R. Bergstrand, I. Wieselgren, B. Olofsson, 1990, Journal of clinical pharmacology.

The Relationship Between Metoprolol Plasma Concentration and Beta1‐Blockade in Healthy Subjects: A Study on Conventional Metoprolol and Metoprolol CR/ZOK Formulations

R. Bergstrand, C. Regårdh, B. Abrahamsson, 1990, Journal of clinical pharmacology.

Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability

M. Hert, I. Wieselgren, M. Wampers, 2002, International journal of psychiatry in clinical practice.

Relationships between social support, social coping and life events in the relapse of schizophrenic patients.

A. Ohman, C. Hultman, I. Wieselgren, 1997, Scandinavian journal of psychology.

The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers

P. Lundborg, B. Abrahamsson, I. Wieselgren, 2004, European Journal of Clinical Pharmacology.

Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients

A. Svedberg, I. Klockhoff, L. Lindström, 1990, Biological Psychiatry.

One‐year outcome in first episode psychosis patients in the Swedish Parachute project

I. Wieselgren, J. Cullberg, M. Mattsson, 2002, Acta psychiatrica Scandinavica.

Electrodermal orienting response, maternal age, and season of birth in schizophrenia

A. Öhman, Lars-Göran Öst, L. Lindström, 1991, Psychiatry Research.

Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia

E. Lindström, L. Knorring, I. Wieselgren, 1994, Acta psychiatrica Scandinavica.

N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

M. Bergström, B. Långström, G. Hagberg, 1998, Psychiatry Research: Neuroimaging.

CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia

L. Lindström, I. Wieselgren, 1998, Psychiatry Research.

Prenatal and neonatal risk factors for schizophrenia

A. Öhman, C. Hultman, S. Cnattingius, 1997, British Journal of Psychiatry.

Tyrosine transport is regulated differently in patients with schizophrenia

J. Andersson, B. Långström, F. Wiesel, 1999, Schizophrenia Research.

Electrodermal activity and social network as predictors of outcome of episodes in schizophrenia.

A. Ohman, C. Hultman, L. Ost, 1996, Journal of abnormal psychology.

Electrodermal activity as a predictor of social functioning in female schizophrenics.

A. Ohman, L. Lindström, I. Wieselgren, 1994, Journal of abnormal psychology.

Electrodermal nonresponding, premorbid adjustment, and symptomatology as predictors of long-term social functioning in schizophrenics.

A. Ohman, A. Öhman, Lars-Göran Öst, 1989, Journal of abnormal psychology.